Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Lewis

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Journal of Cell Science|September 12, 2023
Leucine-rich repeat kinase 2 at a glanceChristiane Zhu, Susanne Herbst, Patrick A Lewis
Expert Opinion on Therapeutic Targets|June 1, 2022
Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson's diseaseJillian H Kluss, Patrick A Lewis, Elisa Greggio
International Journal of Clinical and Experimental Pathology|September 12, 2008
Genetic neuropathology of Parkinson's diseaseMark R Cookson, John Hardy, Patrick A Lewis
Clinical Science (London, England : 1979)|July 11, 2022
The emerging role of LRRK2 in tauopathiesSusanne Herbst, Patrick A Lewis, Huw R Morris
Journal of Neurochemistry|November 7, 2019
Leucine-rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson diseaseSusanna Cogo, Claudia Manzoni, Patrick A Lewis, et al.
Chemistry & Biology|July 2, 2014
Genetic, structural, and molecular insights into the function of ras of complex proteins domainsLaura Civiero, Sybille Dihanich, Patrick A Lewis, et al.
Journal of Parkinson'S Disease|August 14, 2013
LRRK2: cause, risk, and mechanismCoro Paisán-Ruiz, Patrick A Lewis, Andrew B Singleton
Annual Review of Animal Biosciences|November 14, 2025
New Frontiers in Animal Prion DiseasesHasina Abdul, Timm Konold, John Spiropoulos, et al.
Journal of Cell Science|March 10, 2026
Clathrin-mediated endocytosis as an axis for the etiopathogenesis of Parkinson's diseaseAmal Kaci, Susanne Herbst, Claudia Manzoni, et al.
Cell and Tissue Research|January 9, 2018
The LRRK2 signalling systemAlice Price, Claudia Manzoni, Mark R Cookson, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Journal of Cell Science|September 12, 2023
Leucine-rich repeat kinase 2 at a glanceChristiane Zhu, Susanne Herbst, Patrick A Lewis
Expert Opinion on Therapeutic Targets|June 1, 2022
Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson's diseaseJillian H Kluss, Patrick A Lewis, Elisa Greggio
International Journal of Clinical and Experimental Pathology|September 12, 2008
Genetic neuropathology of Parkinson's diseaseMark R Cookson, John Hardy, Patrick A Lewis
Clinical Science (London, England : 1979)|July 11, 2022
The emerging role of LRRK2 in tauopathiesSusanne Herbst, Patrick A Lewis, Huw R Morris
Journal of Neurochemistry|November 7, 2019
Leucine-rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson diseaseSusanna Cogo, Claudia Manzoni, Patrick A Lewis, et al.
Chemistry & Biology|July 2, 2014
Genetic, structural, and molecular insights into the function of ras of complex proteins domainsLaura Civiero, Sybille Dihanich, Patrick A Lewis, et al.
Journal of Parkinson'S Disease|August 14, 2013
LRRK2: cause, risk, and mechanismCoro Paisán-Ruiz, Patrick A Lewis, Andrew B Singleton
Annual Review of Animal Biosciences|November 14, 2025
New Frontiers in Animal Prion DiseasesHasina Abdul, Timm Konold, John Spiropoulos, et al.
Journal of Cell Science|March 10, 2026
Clathrin-mediated endocytosis as an axis for the etiopathogenesis of Parkinson's diseaseAmal Kaci, Susanne Herbst, Claudia Manzoni, et al.
Cell and Tissue Research|January 9, 2018
The LRRK2 signalling systemAlice Price, Claudia Manzoni, Mark R Cookson, et al.
Pageof 12